Some people believe that governments, not private companies, should pay for scientific research, because the results should benefit the whole of society.
To what extent do you agree or disagree?
Give reasons for your answer and include any relevant examples from your own knowledge or experience.
Write at least 250 words.
Why this is Band 6: The position is clear and both sides are discussed with relevant examples. But the argument remains general, with basic linking ('On the one hand'), and there are errors in articles and word form ('all the society', 'get benefit'). Vocabulary is adequate rather than wide.
Science is very important for every country because it improves our health and our life. Some people believe that only the government should give money for research and private companies should not do it. I partly agree with this statement.
On the one hand, the government should pay for research because it is for all the people. If a company pays for research, it wants to make profit. For example, medicine companies make new medicines but they sell them at a very high price, so poor people cannot buy them. Also companies do not want to do research on diseases of poor countries, because they will not earn money. So government must do this type of research, because it is not only thinking about money.
On the other hand, governments do not have enough money for all research. They have to pay for many other things like schools, hospitals and roads. Private companies have a lot of money and they can do research very fast. For example, mobile phones and computers became much better because companies did the research to compete with each other. If only governments do this, then we will not have so many new products. For this reason, we should not stop companies from doing research, as they give us many useful things.
In conclusion, I think that both the governments and the private companies should pay for research. Government should do research for important things like health and environment and the companies can do research for new products. In this way all the society can get benefit from the science.
264 words
Why this is Band 7: A clear position, supported by well-developed paragraphs with examples. Language is accurate and appropriate ('public interest', 'commercial investment', 'first things to be cut'). The argument is sensible, but it is less analytical than in Band 8.
Scientific research has transformed modern life, and its funding is therefore an important question. While some people argue that this should be the responsibility of governments alone, I believe that, although public funding is essential, private companies also have a valuable role to play.
There are strong reasons why governments should pay for much of this work. Most importantly, they can support research that benefits everybody even if it offers no immediate profit. Studies of climate change or of diseases that affect poor countries, for instance, are unlikely to attract commercial investment. Public funding also makes it more likely that the results will be shared openly, whereas a company is likely to keep its findings secret or to charge high prices for them, as often happens with new medicines.
However, it would be unwise to rely on governments alone. Public budgets are limited, and politicians must also pay for healthcare, education and defence, so research may be among the first things to be cut in difficult times. Companies, on the other hand, have both the resources and the motivation to turn scientific ideas into useful products. Competition between technology firms, for example, has led to rapid improvements in mobile phones and computers, which most people now regard as necessary.
In conclusion, I partly agree with the statement. Governments should fund basic research and work that serves the public interest, but private companies should also be encouraged to invest, as long as there are rules to ensure that important discoveries are made available to those who need them.
257 words
Why this is Band 8: Reframes the question ('who should benefit'; 'not who pays but on what terms') and develops an original line of argument. Examples are specific (mRNA vaccines), and it challenges an assumption of the statement (that governments are disinterested). Grammar and vocabulary are sophisticated and highly accurate ('whose practical value may not become apparent', 'Had they been left to').
The question of who should pay for science is ultimately a question of who should benefit from it. I have some sympathy with the view that research ought to be a public responsibility, but I would argue that excluding private companies altogether would slow progress and would not, in itself, guarantee that the benefits are fairly shared.
The case for public funding is at its strongest where the market fails. Basic research, whose practical value may not become apparent for decades, is seldom attractive to firms that must answer to shareholders; the internet and the science underlying the mRNA vaccines both grew out of work that was initially supported by public money. Similarly, no company stands to profit from treating diseases that mainly affect the world's poorest people, or from studies which show that its own products are harmful. In these areas, only governments can be relied upon to act.
Nevertheless, to conclude that governments should pay for everything is to overlook what businesses do best. Translating a laboratory result into a safe, affordable product requires huge sums and a tolerance of failure that few finance ministers could defend to voters. It is also questionable whether state funding is as disinterested as it appears, since governments have their own priorities, and military research has often taken precedence over medicine. Had they been left to public budgets alone, it seems unlikely that areas such as computing would have advanced as rapidly as they have.
The real issue, therefore, is not who pays but on what terms. Where public money has contributed to a discovery, companies that profit from it could reasonably be required to share their data or keep their prices within limits. A partnership of this kind would make better use of both sectors than either could achieve alone, while keeping sight of the principle that science should serve society as a whole.
313 words
How the examiner marks this
Four criteria, each worth 25% of the band. Task 2 counts for two thirds of your Writing band.
1Task response
2Coherence and cohesion
3Lexical resource (vocabulary)
4Grammatical range and accuracy
What makes the difference
Position: Band 6 says both should pay; Band 8 also moves the debate on to the terms under which they should pay.
Analysis: Band 6 says companies want profit; Band 8 explains the market failure involved and which kinds of research are affected.
Examples: Band 6 mentions medicine in general; Band 8 refers specifically to mRNA vaccines and military research.
Grammar: Band 8 has inversion ('Had they been left'), non-defining relative clauses and abstract noun phrases, all accurately used.
Conclusion: Band 6 restates; Band 8 proposes a practical solution, and connects it to the wording of the question.
Tips for this task
At Band 8, you need more than two lists of points. Ask yourself what assumption the statement is making, and challenge it.
Refer to real areas of knowledge, but never invent exact statistics or studies.
Show that you can weigh arguments with phrases like 'The case for X is at its strongest where...'.
Try one or two complex structures per paragraph, but do not force them. Accuracy still counts more than show.
Finish with an idea that follows from your argument, not a new topic.
Real people. Real approvals.
A licensed team that has guided thousands of Indians to their visas and admissions.